Chemed Company Profile (NYSE:CHE)

About Chemed (NYSE:CHE)

Chemed logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Home Health Care
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:CHE
  • CUSIP: 16359R10
  • Web: www.chemed.com
Capitalization:
  • Market Cap: $3.26 billion
  • Outstanding Shares: 16,082,000
Average Prices:
  • 50 Day Moving Avg: $196.05
  • 200 Day Moving Avg: $174.14
  • 52 Week Range: $126.54 - $216.01
P/E:
  • Trailing P/E Ratio: 29.78
  • Foreward P/E Ratio: 23.96
  • P/E Growth: 2.54
Sales & Book Value:
  • Annual Revenue: $1.59 billion
  • Price / Sales: 2.05
  • Book Value: $31.13 per share
  • Price / Book: 6.52
Dividend:
  • Annual Dividend: $1.04
  • Dividend Yield: 0.5%
Profitability:
  • EBIDTA: $217.5 million
  • Net Margins: 6.77%
  • Return on Equity: 23.95%
  • Return on Assets: 13.59%
Debt:
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 0.79%
  • Quick Ratio: 0.76%
Misc:
  • Average Volume: 90,098 shs.
  • Beta: 1.21
  • Short Ratio: 19.23
 

Frequently Asked Questions for Chemed (NYSE:CHE)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Monday, May 15th. Stockholders of record on Thursday, May 25th will be given a dividend of $0.26 per share on Wednesday, June 14th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.51%. The ex-dividend date of this dividend is Tuesday, May 23rd. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its board has approved a stock repurchase program on Monday, April 10th 2017, which allows the company to buyback $100,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 3.3% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) announced its quarterly earnings results on Wednesday, April, 26th. The company reported $1.82 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.78 by $0.04. The company had revenue of $405.90 million for the quarter, compared to analyst estimates of $399.75 million. Chemed had a return on equity of 23.95% and a net margin of 6.77%. The company's quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.62 EPS. View Chemed's Earnings History.

When will Chemed make its next earnings announcement?

Chemed is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for Chemed.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY17 earnings guidance on Wednesday, April, 26th. The company provided earnings per share guidance of $7.80-$8.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.90.

Where is Chemed's stock going? Where will Chemed's stock price be in 2017?

3 analysts have issued twelve-month target prices for Chemed's shares. Their forecasts range from $148.00 to $155.00. On average, they expect Chemed's share price to reach $151.50 in the next year. View Analyst Ratings for Chemed.

Who are some of Chemed's key competitors?

Who are Chemed's key executives?

Chemed's management team includes the folowing people:

  • George J. Walsh III, Independent Chairman of the Board
  • Kevin J. McNamara, President, Chief Executive Officer, Director
  • David Patrick Williams, Chief Financial Officer, Executive Vice President
  • Spencer S. Lee, Executive Vice President
  • Nicholas Michael Westfall, Executive Vice President
  • Michael D. Witzeman, Principal Accounting Officer, Controller
  • Thomas Charles Hutton, Director
  • Joel F. Gemunder, Independent Director
  • Patrick P. Grace, Independent Director
  • Walter L. Krebs, Independent Director

Who owns Chemed stock?

Chemed's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.16%), Vanguard Group Inc. (11.17%), Neuberger Berman Group LLC (6.59%), FMR LLC (5.08%), Riverbridge Partners LLC (4.52%) and Gamco Investors INC. ET AL (3.66%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.

Who sold Chemed stock? Who is selling Chemed stock?

Chemed's stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Bank of New York Mellon Corp, Ameriprise Financial Inc., FMR LLC, Rockefeller Financial Services Inc., Gabelli Funds LLC, Renaissance Technologies LLC and Gamco Investors INC. ET AL. Company insiders that have sold Chemed stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.

Who bought Chemed stock? Who is buying Chemed stock?

Chemed's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., State Street Corp, Oppenheimer Asset Management Inc., Neuberger Berman Group LLC, Bank of America Corp DE, Seizert Capital Partners LLC and Karp Capital Management Corp. View Insider Buying and Selling for Chemed.

How do I buy Chemed stock?

Shares of Chemed can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of Chemed stock can currently be purchased for approximately $202.98.


MarketBeat Community Rating for Chemed (NYSE CHE)
Community Ranking:  2.0 out of 5 ( )
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  153
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Chemed (NYSE:CHE) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $151.50 (25.36% downside)

Analysts' Ratings History for Chemed (NYSE:CHE)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/1/2016Royal Bank of CanadaReiterated RatingSector Perform$162.00 -> $148.00N/AView Rating Details
9/27/2016Oppenheimer Holdings Inc.Reiterated RatingOutperform$155.00N/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
9/15/2015Deutsche Bank AGReiterated RatingBuyN/AView Rating Details
(Data available from 5/29/2015 forward)

Earnings

Earnings History for Chemed (NYSE:CHE)
Earnings by Quarter for Chemed (NYSE:CHE)
Earnings History by Quarter for Chemed (NYSE:CHE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/24/2017        
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Chemed (NYSE:CHE)
2017 EPS Consensus Estimate: $7.93
2018 EPS Consensus Estimate: $8.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20171$1.96$1.96$1.96
Q4 20171$2.31$2.31$2.31
Q1 20181$1.92$1.92$1.92
Q2 20181$2.03$2.03$2.03
Q3 20181$2.10$2.10$2.10
Q4 20181$2.44$2.44$2.44
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Chemed (NYSE:CHE)
Next Dividend:6/14/2017
Annual Dividend:$1.04
Dividend Yield:0.51%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:16.59% (Trailing 12 Months of Earnings)
13.08% (Based on This Year's Estimates)
12.28% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Chemed (NYSE:CHE)

Dividend History by Quarter for Chemed (NYSE:CHE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/15/2017Quarterly$0.260.51%5/23/20175/25/20176/14/2017
2/17/2017quarterly$0.260.59%2/23/20172/27/20173/20/2017
11/4/2016quarterly$0.260.76%11/9/201611/14/201612/5/2016
8/5/2016quarterly$0.260.72%8/11/20168/15/20169/2/2016
5/16/2016quarterly$0.240.76%5/24/20165/26/20166/15/2016
2/19/2016quarterly$0.240.75%2/25/20162/29/20163/21/2016
11/6/2015quarterly$0.240.63%11/12/201511/16/201512/7/2015
8/7/2015quarterly$0.240.63%8/13/20158/17/20159/4/2015
5/18/2015quarterly$0.220.71%5/26/20155/28/20156/17/2015
2/20/2015quarterly$0.220.77%2/26/20153/2/20153/23/2015
11/7/2014quarterly$0.220.81%11/13/201411/17/201412/8/2014
8/11/2014quarterly$0.220.88%8/14/20148/18/20149/13/2014
8/8/2014quarterly$0.228/14/20148/18/20149/3/2014
5/19/2014quarterly$0.200.91%5/27/20145/29/20146/18/2014
2/21/2014quarterly$0.200.94%2/27/20143/3/20143/24/2014
11/8/2013quarterly$0.201.13%11/14/201311/18/201312/9/2013
8/2/2013quarterly$0.201.1%8/8/20138/12/20139/3/2013
5/20/2013quarterly$0.181.05%5/28/20135/30/20136/19/2013
2/20/2013quarterly$0.180.92%2/28/20133/4/20133/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Chemed (NYSE:CHE)
Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 99.72%
Insider Trades by Quarter for Chemed (NYSE:CHE)
Institutional Ownership by Quarter for Chemed (NYSE:CHE)
Insider Trades by Quarter for Chemed (NYSE:CHE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.46View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.00View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.00View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.00View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.38View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Chemed (NYSE:CHE)
Latest Headlines for Chemed (NYSE:CHE)
Source:
DateHeadline
americanbankingnews.com logoChemed Co. (che) to Issue $0.26 Quarterly Dividend
www.americanbankingnews.com - May 16 at 10:22 AM
finance.yahoo.com logoChemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend
finance.yahoo.com - May 15 at 4:01 PM
finance.yahoo.com logoChemed Corporation to Present at the Bank of America Merrill Lynch 2017 Health Care Conference
finance.yahoo.com - May 11 at 4:54 PM
americanbankingnews.com logoInsider Buying: Chemed Co. (CHE) Director Acquires 94 Shares of Stock
www.americanbankingnews.com - May 5 at 5:14 PM
americanbankingnews.com logoChemed Co. (CHE) Director Sells $81,940.00 in Stock
www.americanbankingnews.com - May 5 at 4:51 PM
americanbankingnews.com logoFavorable News Coverage Unlikely to Affect Chemed (CHE) Share Price
www.americanbankingnews.com - May 4 at 5:14 PM
americanbankingnews.com logoChemed Co. (CHE) Insider Sells $820,440.00 in Stock
www.americanbankingnews.com - May 2 at 6:46 PM
americanbankingnews.com logoSpencer S. Lee Sells 1,000 Shares of Chemed Co. (CHE) Stock
www.americanbankingnews.com - May 1 at 8:24 PM
finance.yahoo.com logoChemed Corp. :CHE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 4:14 PM
americanbankingnews.com logoOppenheimer Holdings Weighs in on Chemed Co.'s Q3 2018 Earnings (CHE)
www.americanbankingnews.com - May 1 at 1:04 PM
americanbankingnews.com logoFavorable Press Coverage Somewhat Unlikely to Affect Chemed (CHE) Stock Price
www.americanbankingnews.com - April 29 at 5:47 PM
finance.yahoo.com logoEdited Transcript of CHE earnings conference call or presentation 27-Apr-17 2:00pm GMT
finance.yahoo.com - April 28 at 5:14 PM
finance.yahoo.com logoChemed Reports First-Quarter 2017 Results
finance.yahoo.com - April 27 at 4:43 PM
americanbankingnews.com logoChemed Co. (CHE) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - April 27 at 12:20 AM
americanbankingnews.com logoChemed Co. (CHE) Announces Earnings Results
www.americanbankingnews.com - April 26 at 11:24 PM
americanbankingnews.com logoChemed (CHE) Earns Daily News Sentiment Score of 0.34
www.americanbankingnews.com - April 26 at 9:00 PM
americanbankingnews.com logoChemed Co. (CHE) Releases FY17 Earnings Guidance
www.americanbankingnews.com - April 26 at 6:49 PM
marketbeat.com logoChemed posts 1Q profit
marketbeat.com - April 26 at 6:28 PM
americanbankingnews.com logoChemed (CHE) Given Daily News Impact Rating of 0.31
www.americanbankingnews.com - April 20 at 4:11 PM
bizjournals.com logoEXCLUSIVE: How Facebook fueled the Courier's stock contest leader
www.bizjournals.com - April 17 at 4:06 PM
americanbankingnews.com logoChemed (CHE) Earning Somewhat Critical News Coverage, Study Finds
www.americanbankingnews.com - April 17 at 2:54 PM
americanbankingnews.com logoChemed (CHE) Earns Media Impact Score of 0.50
www.americanbankingnews.com - April 14 at 9:21 AM
americanbankingnews.com logoChemed (CHE) Board of Directors Initiates Share Buyback Plan
www.americanbankingnews.com - April 10 at 9:14 AM
finance.yahoo.com logoChemed To Report First-Quarter 2017 Earnings April 26, Related Conference Call To Be Held On April 27
finance.yahoo.com - April 7 at 8:58 AM
biz.yahoo.com logoCHEMED CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - April 3 at 4:40 PM
finance.yahoo.com logoChemed (CHE) Up 6.4% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 21 at 8:01 AM
finance.yahoo.com logoChemed Corporation to Present at the Oppenheimer 27th Annual Healthcare Conference
finance.yahoo.com - March 15 at 4:38 PM
finance.yahoo.com logo8:30 am Chemed's Board authorizes an additional $100 million for stock repurchase under its existing share repurchase program
finance.yahoo.com - March 13 at 12:43 PM
finance.yahoo.com logoChemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase
finance.yahoo.com - March 13 at 12:43 PM
biz.yahoo.com logoCHEMED CORP Files SEC form 8-K, Other Events
biz.yahoo.com - March 13 at 12:43 PM
finance.yahoo.com logoCHEMED CORP Financials
finance.yahoo.com - March 3 at 4:17 PM
biz.yahoo.com logoCHEMED CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - February 27 at 2:49 PM
us.rd.yahoo.com logoEdited Transcript of CHE earnings conference call or presentation 16-Feb-17 3:00pm GMT
us.rd.yahoo.com - February 17 at 5:56 PM
capitalcube.com logoChemed Corp. :CHE-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017
us.rd.yahoo.com - February 17 at 5:56 PM
biz.yahoo.com logoCHEMED CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year
biz.yahoo.com - February 17 at 5:56 PM
streetinsider.com logoChemed Corporation (CHE) Reports In-Line Q4 EPS
www.streetinsider.com - February 16 at 4:22 PM
rttnews.com logoChemed Corp. Profit Climbs 2% In Q4
www.rttnews.com - February 16 at 4:22 PM
seekingalpha.com logoChemed's (CHE) CEO Kevin McNamara on Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - February 16 at 4:22 PM
reuters.com logoBRIEF-Chemed Q4 GAAP earnings per share $1.94
www.reuters.com - February 16 at 4:22 PM
biz.yahoo.com logoChemed Corp Earnings Call scheduled for 10:00 am ET today
biz.yahoo.com - February 16 at 4:22 PM
finance.yahoo.com logoChemed Corporation to Present at the 2017 RBC Capital Markets’ Global Healthcare Conference
finance.yahoo.com - February 16 at 4:22 PM
biz.yahoo.com logoQ4 2016 Chemed Corp Earnings Release - After Market Close
us.rd.yahoo.com - February 16 at 9:55 AM
us.rd.yahoo.com logoChemed Reports Fourth-Quarter 2016 Results
us.rd.yahoo.com - February 16 at 9:55 AM
us.rd.yahoo.com logo4:19 pm Chemed beats by $0.03, misses on revs; guides FY17 EPS above consensus
us.rd.yahoo.com - February 16 at 9:55 AM
biz.yahoo.com logoCHEMED CORP Files SEC form 8-K, Results of Operations and Financial Condition
us.rd.yahoo.com - February 16 at 9:55 AM
sg.finance.yahoo.com logoChemed posts 4Q profit
us.rd.yahoo.com - February 16 at 9:55 AM
finance.yahoo.com logoChemed To Report Fourth-Quarter 2016 Earnings February 15, Related Conference Call To Be Held On February 16
finance.yahoo.com - January 20 at 5:25 PM
forbes.com logoEx-Dividend Reminder: Eli Lilly, Teleflex and Chemed
www.forbes.com - November 9 at 12:06 PM
finance.yahoo.com logoChemed Corporation to Present at the 2016 Credit Suisse Healthcare Conference
finance.yahoo.com - November 1 at 4:16 PM
biz.yahoo.com logoCHEMED CORP Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - November 1 at 8:20 AM

Social

Chart

Chemed (CHE) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff